Fonar (FONR) Competitors $15.60 -0.14 (-0.89%) As of 10/9/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. DCTH, TMCI, CARL, NPCE, DRTS, RXST, TCMD, BWAY, SMTI, and SIShould you be buying Fonar stock or one of its competitors? The main competitors of Fonar include Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Carlsmed (CARL), NeuroPace (NPCE), Alpha Tau Medical (DRTS), RxSight (RXST), Tactile Systems Technology (TCMD), Brainsway (BWAY), Sanara MedTech (SMTI), and Shoulder Innovations (SI). These companies are all part of the "medical equipment" industry. Fonar vs. Its Competitors Delcath Systems Treace Medical Concepts Carlsmed NeuroPace Alpha Tau Medical RxSight Tactile Systems Technology Brainsway Sanara MedTech Shoulder Innovations Fonar (NASDAQ:FONR) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Is FONR or DCTH more profitable? Fonar has a net margin of 7.99% compared to Delcath Systems' net margin of 3.18%. Delcath Systems' return on equity of 6.91% beat Fonar's return on equity.Company Net Margins Return on Equity Return on Assets Fonar7.99% 5.22% 3.91% Delcath Systems 3.18%6.91%5.80% Does the media prefer FONR or DCTH? In the previous week, Delcath Systems had 7 more articles in the media than Fonar. MarketBeat recorded 8 mentions for Delcath Systems and 1 mentions for Fonar. Fonar's average media sentiment score of 1.91 beat Delcath Systems' score of 0.48 indicating that Fonar is being referred to more favorably in the media. Company Overall Sentiment Fonar Very Positive Delcath Systems Neutral Do institutionals & insiders have more ownership in FONR or DCTH? 50.6% of Fonar shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 1.6% of Fonar shares are owned by company insiders. Comparatively, 17.4% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer FONR or DCTH? Delcath Systems has a consensus target price of $24.50, indicating a potential upside of 125.18%. Given Delcath Systems' stronger consensus rating and higher possible upside, analysts plainly believe Delcath Systems is more favorable than Fonar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fonar 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Delcath Systems 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has more risk and volatility, FONR or DCTH? Fonar has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Which has higher valuation & earnings, FONR or DCTH? Fonar has higher revenue and earnings than Delcath Systems. Fonar is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFonar$104.35M0.92$8.33M$1.2312.60Delcath Systems$37.21M10.23-$26.39M$0.05217.60 SummaryDelcath Systems beats Fonar on 10 of the 16 factors compared between the two stocks. Get Fonar News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFonarMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$97.64M$10.84B$6.13B$10.65BDividend YieldN/A1.86%5.66%4.70%P/E Ratio12.6021.0885.8327.64Price / Sales0.9228.27624.67141.10Price / Cash7.4925.3838.3262.20Price / Book0.603.4613.066.79Net Income$8.33M$208.83M$3.30B$275.88M7 Day Performance-3.61%0.78%3.71%1.90%1 Month Performance-1.77%3.86%10.70%8.90%1 Year Performance-0.06%-3.61%84.93%36.28% Fonar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFonar1.5577 of 5 stars$15.50-1.5%N/A-1.9%$97.64M$104.35M12.60480Positive NewsDCTHDelcath Systems2.6089 of 5 stars$10.98+1.6%$24.50+123.2%+27.8%$387.59M$70.24M221.6060Analyst ForecastTMCITreace Medical Concepts2.3784 of 5 stars$6.12-2.9%$9.83+60.7%+15.3%$386.29M$209.36M-7.74250Analyst ForecastGap UpCARLCarlsmedN/A$13.80-4.7%N/AN/A$366.80M$27.17M0.00100NPCENeuroPace3.7173 of 5 stars$10.76-0.1%$16.60+54.3%+76.6%$355.94M$79.91M-12.81170News CoveragePositive NewsAnalyst ForecastDRTSAlpha Tau Medical2.0933 of 5 stars$4.15-1.8%$9.00+117.1%+71.2%$351.66MN/A-8.6480Positive NewsAnalyst ForecastRXSTRxSight2.7206 of 5 stars$8.35-1.7%$10.00+19.8%-83.6%$341.68M$139.93M-10.44220Analyst ForecastTCMDTactile Systems Technology3.6284 of 5 stars$14.94-1.5%$16.83+12.7%+2.8%$332.93M$298.85M24.091,037Analyst ForecastBWAYBrainsway3.3175 of 5 stars$15.11-0.8%$18.00+19.2%+57.5%$286.59M$46.08M58.10120Positive NewsSMTISanara MedTech2.4286 of 5 stars$31.22-0.1%$50.00+60.2%-1.5%$277.92M$97.24M-26.9160News CoverageAnalyst ForecastSIShoulder Innovations2.715 of 5 stars$13.13+0.3%$19.60+49.3%N/A$267.23M$37.32M-0.4461 Related Companies and Tools Related Companies Delcath Systems Competitors Treace Medical Concepts Competitors Carlsmed Competitors NeuroPace Competitors Alpha Tau Medical Competitors RxSight Competitors Tactile Systems Technology Competitors Brainsway Competitors Sanara MedTech Competitors Shoulder Innovations Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredElon callingElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fonar Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Fonar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
